Norman Sussman

Director, STEM CELL INNOVATIONS, INC.

Companies

DURECT CORPChief Medical Officer Nov 4, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

DURECT CORP0 shares²Sep 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 11, 2025Returned to company 46,425 shares of DURECT CORP²
Jul 11, 2025Granted 46,425 shares of DURECT CORP³
Dec 10, 2021Sold 9,000 shares at $1.06 of DURECT CORP⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDURECT CORP, Chief Medical Officer
2
SEC EDGARDURECT CORP shares after the filing of Sep 11, 2025
3
SEC EDGARForm 4 filed Jul 15, 2025
4
SEC EDGARForm 4 filed Sep 11, 2024